Humans are constantly bombarded with streams of information from multiple sensory modalities (e.g. auditory and visual) that must be rapidly processed to execute appropriate behaviours. Reference Mayer, Franco, Canive and Harrington1 Cognitive control refers to the ability to facilitate goal-directed behaviours while suppressing inappropriate and/or distracting stimuli and behaviours, and has recently been expanded to include working memory paradigms. Reference Lesh, Westphal, Niendam, Yoon, Minzenberg and Ragland2 Although deficits in cognitive control are commonly reported in patients with schizophrenia, Reference Lesh, Niendam, Minzenberg and Carter3 the majority of previous schizophrenia studies have utilised unisensory stimuli, Reference Tregellas, Smucny, Eichman and Rojas4,Reference Verleger, Talamo, Simmer, Smigasiewicz and Lencer5 with only a single study employing a more realistic multisensory approach. Reference Smucny, Rojas, Eichman and Tregellas6 Unisensory studies may not adequately capture the complex environment that is typical in occupational and interpersonal settings where patients with schizophrenia have been shown to exhibit deficits associated with cognition. Thus, to understand the underlying neuronal processes of cognitive control in real-world environments, a multisensory approach is needed.
There are two potential theories regarding cognitive control deficits in patients with schizophrenia. The first theory suggests that poor performance in patients results from dysfunction within the cognitive control network (CCN) during trials with conflicting (i.e. incongruent trials) relative to non-conflicting (i.e. congruent trials) information. Reference Smucny, Rojas, Eichman and Tregellas6–Reference Sugranyes, Kyriakopoulos, Dima, O'Muircheartaigh, Corrigall and Pendelbury8 The core CCN in healthy controls includes the dorsal medial prefrontal cortex, dorsolateral and ventrolateral prefrontal cortex (lateral prefrontal cortex), anterior insula and the inferior parietal lobes. Reference Ridderinkhof, van den Wildenberg, Segalowitz and Carter9 Previous neuroimaging studies have reported abnormalities within the lateral prefrontal cortex, dorsal medial prefrontal cortex, posterior parietal cortex, lateral temporal cortex and thalamus for patients with schizophrenia relative to healthy controls across a variety of tasks. Reference Minzenberg, Laird, Thelen, Carter and Glahn10 However, reduced Reference Weiss, Siedentopf, Golaszewski, Mottaghy, Hofer and Kremser7,Reference Ungar, Nestor, Niznikiewicz, Wible and Kubicki11 and increased Reference Potkin, Turner, Brown, McCarthy, Greve and Glover12,Reference Weiss, Golaszewski, Mottaghy, Hofer, Hausmann and Kemmler13 prefrontal activation have been reported, as well as a combination of both findings. Reference Edwards, Barch and Braver14,Reference Vercammen, Morris, Green, Lenroot, Kulkarni and Carr15 The single imaging study examining multisensory cognitive control in patients with schizophrenia reported hypoactivation within lateral prefrontal cortex, temporoparietal juncture and medial temporal regions. Reference Smucny, Rojas, Eichman and Tregellas6
Although top-down allocation of attention necessitates the recruitment of the CCN, competent performance is also dependent on the processing of stimuli within the sensory cortex. A second theory therefore suggests that dysfunction within sensory cortex contributes to downstream cognitive control deficits in patients with schizophrenia. Reference Tregellas, Smucny, Eichman and Rojas4,Reference Verleger, Talamo, Simmer, Smigasiewicz and Lencer5,Reference Brenner, Krishnan, Vohs, Ahn, Hetrick and Morzorati16 These deficits have been observed in both auditory and visual steady state responses, Reference Brenner, Krishnan, Vohs, Ahn, Hetrick and Morzorati16 mismatch negativity, Reference Rissling, Park, Young, Rissling, Sugar and Sprock17 abnormal auditory gating Reference Patterson, Hetrick, Boutros, Jin, Sandman and Stern18 and reduced visual evoked potentials. Reference Verleger, Talamo, Simmer, Smigasiewicz and Lencer5 Conversely, hyperactivation of auditory cortex Reference Mayer, Ruhl, Merideth, Ling, Hanlon and Bustillo19 and primary visual cortex Reference Backes, Kellermann, Voss, Kramer, Depner and Schneider20 has also been reported, suggestive of over-processing of sensory stimuli. Finally, a direct interaction exists between attentionally demanding multisensory conditions (requiring more cognitive control) and the degree of neuronal activation within unisensory cortex. These attention-related modulations (ARMs) include enhanced neural responses (i.e. upregulation) within primary and secondary sensory cortices for the attended stimuli and suppressed responses for the ignored stimuli, the appearance of new waveforms, as well as more synchronous neuronal spiking. Reference Mayer, Franco, Canive and Harrington1,Reference Baier, Kleinschmidt and Muller21,Reference Weissman, Warner and Woldorff22
Thus, multisensory cognitive control tasks are uniquely poised to distinguish between deficits resulting from top-down abnormalities within the CCN (incongruent auditory/visual trials v. congruent auditory/auditory or visual/visual trials), basic deficits in neurovascular properties within unisensory cortex, and the direct modulation of unisensory cortex (ARMs). We hypothesised that patients with schizophrenia would exhibit deficits within the CCN specifically during cognitive control (incongruent v. congruent trials), whereas deficits within the unisensory cortex would be seen generally (across both incongruent and congruent trials). In addition, we predicted that patients with schizophrenia would fail to exhibit upregulation of unimodal sensory cortical areas (ARMs) to attended stimuli at increasing cognitive loads (high frequency stimuli relative to low frequency stimuli) as has been observed in healthy populations. Reference Mayer, Franco, Canive and Harrington1
Thirty-seven clinically stable patients with schizophrenia and 37 age- and gender-matched healthy controls were included. Data from one patient were lost secondary to acquisition problems, and one patient was an outlier (three standard deviations) relative to their cohort on two of six motion parameters (frame-wise displacement). Two patients with schizophrenia performed below chance levels (based on a binomial distribution) on the task, leaving a total of 33 patients with schizophrenia (29 males; 36.0 years old (s.d. = 13.6)) and 33 matched healthy controls (29 males; 34.6 years old (s.d. = 12.6)) for final analyses. Informed consent was provided according to institutional guidelines.
Inclusion criteria for patients with schizophrenia included a diagnosis of schizophrenia based on the Structured Clinical Interview for DSM-IV-TR and age of 18–65 years. Most patients with schizophrenia (32/33) were on a variety of antipsychotic medications (28/32 patients atypical) such that olanzapine equivalency scores were calculated. Reference Gardner, Murphy, O'Donnell, Centorrino and Baldessarini23 Exclusion criteria for both groups included a history of neurological disorder, head trauma with loss of consciousness greater than 5 min, mental retardation, inadequate hearing (tested with the calibrated finger rub auditory screening test), active substance dependence or misuse within the past year and lifetime history of dependence or use within the last 12 months of phencyclidine, amphetamines or cocaine. Additional exclusion criteria for healthy controls included a current or past psychiatric disorder (with the exception of one lifetime depressive episode), depression or antidepressant use within the past 6 months, lifetime antidepressant use of more than 1 year, and history of a psychotic disorder in a first-degree relative. All participants refrained from smoking for at least 1 h before scanning.
Neuropsychological and clinical assessment
All participants completed the Wechsler Test of Adult Reading (WTAR). Patients with schizophrenia completed the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) battery, Positive and Negative Syndrome Scale (PANSS), Calgary Depression Scale, Clinical Global Impression, Fagerstrom Test for Nicotine Dependence (FTND), a modified version of the Simpson Angus Scale for Parkinsonism (SAS), Abnormal Involuntary Movements Scale (AIMS) for tardive dyskinesia, Barnes Akathisia Scale (BAS), urine drug screening and the UCSD Performance Based Skills Assessment test (UPSA-2). Please see online supplemental Methods for references associated with all clinical assessments.
The task was identical to previous publications. Reference Mayer, Wilcox, Teshiba, Ling and Yang24 Congruent or incongruent multisensory (auditory and visual) numeric stimuli (Fig. 1A and 1B) were simultaneously presented at either low (0.33 Hz; 3 trials/block) or high (0.66 Hz; 6 trials/block) frequency rates in 10-second blocks. For each block, the stream of target numbers (one, two or three) was preceded by a cue word, ‘HEAR’ or ‘LOOK’. If the cue was ‘HEAR’, participants were instructed to respond via a right-handed button press to aurally presented target stimuli and ignore simultaneously presented visual numbers (attend-auditory condition). When the cue was ‘LOOK’, visually presented stimuli were the targets and participants were instructed to ignore auditory stimuli (attend-visual condition). The inter-block intervals varied between 8, 10 and 12 s to decrease temporal expectations and permit modelling of the baseline response. Order of blocks was pseudorandom, with a total of 432 trials presented across six separate imaging runs. Median reaction times were used as measures of central tendency to reduce the influence of skew. Accuracy was analysed using ranking of percentage of errors in each trial type to account for deviations in normality. 2×2×2 (group (patients with schizophrenia v. healthy controls)×condition (congruent v. incongruent)× frequency (0.33 Hz v. 0.66 Hz)) mixed-measures analysis of variance (ANOVAs) were conducted separately on attend-auditory and attend-visual conditions for both accuracy and response time data.
Magnetic resonance imaging and statistical analyses
Magnetic resonance imaging (MRI) data including T1 images and echo-planar imaging (EPI) were collected on a Siemens 3T Trio Tim scanner with a 12 channel head coil. EPI data were collected using a single-shot, gradient-echo sequence (repetition time (TR) = 2000 ms; voxel size: 3.75×3.75×4.55 mm; see online supplemental Methods). Functional imaging maps were calculated using the Analysis of Functional NeuroImages (AFNI) software (http://afni.nimh.nih.gov). Standard pre-processing steps included motion correction, slice timing correction, smoothing (8 mm full-width at half-max Gaussian kernel) and spatial normalisation. A voxel-wise deconvolution analysis generated a single haemodynamic response function (HRF) for each trial-type relative to baseline (visual fixation plus baseline gradient noise) and was based on the first 22 s post-stimulus onset. Error trials were modelled separately. Reference Mayer, Teshiba, Franco, Ling, Shane and Stephen25 Percent signal change (PSC) for correct trials was calculated by summing beta coefficients for images occurring 6–14 s post-cue onset and dividing by the average model intercept.
Similar to accuracy and response time data, two parallel whole-brain voxel-wise, 2×2×2 (group (patients with schizophrenia v. healthy controls)×condition (congruent v. incongruent)×frequency (0.33 Hz v. 0.66 Hz)) mixed-measures analysis of covariance (ANCOVAs) were conducted on auditory and visual modalities separately using 3dMVM in AFNI. In this analytic framework, our predictions of increased abnormalities during cognitive control are specifically tested by the group× condition (increased deficits for patients with schizophrenia on incongruent trials) and group×condition×frequency (worse performance under higher cognitive loads) interactions, whereas our prediction of increased difficulty with processing multisensory stimuli is tested by the main effect of group. All voxel-wise results were corrected for false positives at P<0.05 based on 10 000 Monte-Carlo simulations implemented in AFNI (cluster level = parametric threshold P<0.005; minimum cluster size 2431 μl). Clusters that survived false positive correction but exhibited greater than 75% overlap with a white matter/ventricular exclusion map were also excluded (see online supplemental Methods).
Individual T 1 data were segmented through the FreeSurfer reconstruction pipeline, with regions of interest (ROI) defined by standard labels (see online supplemental Methods). To calculate how unisensory cortex was attentionally modulated in the presence of identical sensory stimulation (ARMs), PSC data were subtracted in the expected direction of positive modulation for auditory (attend-auditory trials – attend-visual trials) and visual (attend-visual trials – attend-auditory trials) cortex for each frequency, collapsing across congruent and incongruent trials. This was followed by 2×2 (group×frequency) ANOVAs and one-sample t-tests to ensure that resulting subtraction maps were not equivalent to the null distribution (see online supplemental Methods). The group×frequency interaction specifically tested the hypothesis that patients with schizophrenia would fail to exhibit ARMs at increasing cognitive loads (faster rate of stimulus presentation). Multivariate analysis of covariance (MANCOVAs) were performed separately for primary and secondary auditory and visual cortex volumes using intracranial volume (ICV) as the covariate.
Demographics and clinical data
There were no significant differences in age between the two groups (P>0.10). Significant group differences were observed in education (t 64 = 2.1, P<0.05) and estimate of pre-morbid intelligence (t 40.5 = 2.6, P<0.05), with patients with schizophrenia exhibiting lower estimated intelligence than healthy controls. See Table 1 for remainder of clinical demographics.
|Patients with schizophrenia||Healthy controls|
|Education level a||12.52||1.48||13.45||2.08||0.039||0.52|
|Age at onset, years||21.91||7.64|
|Illness duration, years||13.34||10.38|
|Clinical Global Impression||3.73||0.72|
|Calgary Depression Scale||0.61||0.70|
a. Education level was determined based on number of years in school.
WTAR, Wechsler Test of Adult Reading; PANSS, Positive and Negative Syndrome Scale; UPSA, UCSD Performance Based Skills Assessment; MATRICS, Measurement and Treatment Research to Improve Cognition in Schizophrenia; FTND, Fagerstrom Test for Nicotine Dependence; SAS, Simpson Angus Scale; AIMS, Abnormal Involuntary Movements Scale; BAS, Barnes Akathisia Scale.
Multisensory selective attention task behavioural data
The ranked accuracy data were analysed separately for attend-auditory and attend-visual trails using 2×2×2 (group (patients with schizophrenia v. healthy controls)×condition (congruent v. incongruent)×frequency (0.33 Hz v. 0.66 Hz)) ANOVAs. There were no significant effects for any factors or interactions in the attend-visual trials. The three-way interaction was significant for the attend-auditory condition (F 1,64 = 7.9, P<0.05), with follow-up analyses indicating that patients were less accurate on high-frequency, incongruent trials.
During attend-visual trials (Fig. 1C), ANOVA results for reaction time data indicated significant main effects of condition (F 1,64 = 87.7, P<0.05), frequency (F 1,64 = 126.7, P<0.05) and group (F 1,64 = 6.1, P<0.05), with faster response times for congruent (548.0 ms (s.d. = 78.4)) relative to incongruent (607.8 ms (s.d. = 106.0)) and high (546.8 ms (s.d. = 85.2)) relative to low (609.0 ms (s.d. = 98.7)) frequency trials. Healthy controls (551.7 ms (s.d. = 73.2)) also responded faster to targets relative to patients with schizophrenia (604.1 ms (s.d. = 97.4)). Non-significant trends were observed for condition×group (F 1,64 = 2.9, P = 0.096) and frequency×condition (F 1,64 = 3.1, P = 0.082) interactions. The non-significant condition×group interaction indicated increased slowing for patients with schizophrenia while ignoring auditory stimuli (incongruent–congruent trials 70.6 ms (s.d. = 57.5)) relative to healthy controls (incongruent–congruent trials 49.0 ms (s.d.= 45.6)) beyond general response slowing.
For attend-auditory trials (Fig. 1D), significant main effects of both condition (F 1,64 = 78.1, P<0.05) and frequency (F 1,64 = 107.4, P<0.05) were noted, with participants responding more rapidly to congruent (586.6 ms (s.d. = 86.5)) compared with incongruent (657.6 ms (s.d. = 104.9)) trials, as well as to higher (582.7 ms (s.d. = 87.9)) relative to lower (661.5 ms (s.d. = 102.7)) frequency trials. In addition, the main effect of group was also significant (F 1,64 = 6.6, P<0.05), with patients with schizophrenia (649.5 ms (s.d. = 98.3)) responding more slowly to attend-auditory trials relative to healthy controls (594.7 ms (s.d. = 73.8)). No interaction effects were significant (P<0.10).
Motion parameter analyses
Two multivariate analyses of variance (MANOVAs) were performed to examine potential group differences in frame-wise displacement for all six motion parameters. Although the group effect was not significant for the translational motion MANOVA (P>0.10), there was a significant effect for the rotational motion MANOVA (F 3,62 = 4.04, P<0.05), with univariate measures indicating significantly increased motion for patients with schizophrenia (pitch: F 1,64 = 8.29, P<0.05; yaw: F 1,64 = 7.67, P<0.05). The utilisation of covariates in the presence of group differences is actively debated, Reference Miller and Chapman26 but motion can produce spurious activation. Reference Power, Barnes, Snyder, Schlaggar and Petersen27 Primary functional analyses were therefore performed with frame-wise displacement as a covariate, whereas analyses without frame-wise displacement are reported in the online supplement. In addition, more aggressive strategies Reference Power, Barnes, Snyder, Schlaggar and Petersen27 for eliminating individuals with excessive motion were also evaluated (see online supplemental Results).
Attend-visual fMRI results
A voxel-wise, 2×2×2 (group×condition×frequency) mixed-measures ANCOVA was performed for the attend-visual condition. Contrary to a priori predictions, neither the group×condition nor the group×condition×frequency interaction was significant. Regions exhibiting increased activation for incongruent relative to congruent trials (CCN; see online supplement Fig. DS1 for effects collapsed across group and Fig. DS2 for individual group effects) included bilateral dorsal medial prefrontal cortex (Brodmann areas (BAs) 6/9/24/32/33), bilateral anterior insula, lateral prefrontal cortex extending into the precentral gyrus (left BAs 4/6/8/9/10/13/44/45/46/47; right BAs 6/9/13/44/45/46/47), bilateral middle and posterior superior temporal gyri/sulci extending into inferior parietal lobule (BAs 13/21/22/39/40), the left posterior parietal cortex (BAs 19/39/40) and left precuneus/posterior cingulate gyrus (BAs 7/31). Increased activation for incongruent trials was also observed within the bilateral thalamus, basal ganglia and midbrain nuclei during the attend-visual condition.
A main effect of group was also present in several cortical regions during attend-visual conditions (Fig. 2). The findings were represented by two primary patterns of patient hyperactivation and potentially failed deactivation, supporting the hypothesis of a generalised deficit in unisensory cortex activation in patients with schizophrenia. Specifically, patient hyperactivation was observed in the right (BAs 13/38/40/43) auditory cortex, as well as left (BAs 2/5/7/40) and right (BAs /2/3/4/5/6/7/40) sensorimotor cortex, posterior parietal cortex and precuneus. For the second pattern, healthy controls exhibited deactivation within right extrastriate primary visual cortex (BAs 18/19/29/30/31), whereas patients with schizophrenia exhibited baseline activity. Finally, healthy controls displayed increased activation in lobules VII and VIII of the left cerebellum relative to patients with schizophrenia. Similar results were obtained when individuals with greater than 0.50 mean frame-wise displacement were excluded from analyses. Additional regions of patient hyperactivation (left auditory cortex) and healthy control deactivation (left visual cortex, paracentral lobule and cingulate cortex) were observed when frame-wise displacement was excluded from the model as a covariate (see online supplemental Results; Fig. DS3). Qualitative examination of the HRF indicated both an increased amplitude and duration of response for patients with schizophrenia, with little evidence of a post-undershoot (online Fig. DS4).
Due to null effects and concerns about insufficient power, supplemental analyses were also conducted on the CCN to determine effect sizes. Specifically, regions within the CCN were first identified by comparing the intersection of the within-participant comparisons for the contrast of incongruent v. congruent trials (see online Fig. DS2 for individual group maps). Table 2 indicates the regions of common activation across both patients with schizophrenia and healthy controls for this contrast as well as the respective effects sizes. For all regions within the CCN, effect sizes were typically in the small range (range −0.22 to 0.03).
|Size, μL||Patients with schizophrenia
n (mean) s.d.
n (mean) s.d.
|L IPFC||19 383||33 (0.094) 0.105||33 (0.121) 0.134||−0.22|
|L pSTS||7121||33 (0.090) 0.100||33 (0.099) 0.120||−0.09|
|R IPFC||2255||33 (0.083) 0.135||33 (0.078) 0.134||0.03|
|B ACC||1853||33 (0.056) 0.099||33 (0.062) 0.109||−0.05|
|L dACC/p-SMA||1777||33 (0.082) 0.126||33 (0.113) 0.153||−0.22|
B, L, R, bilateral, left, right; lPFC, lateral prefrontal cortex; pSTS, posterior superior temporal sulcus; dACC, dorsal anterior cingulate gyrus; p-SMA, pre-supplementary motor area.
The group×frequency interaction (see online Fig. DS5) was significant within the culmen and declive bilaterally and the right posterior parietal cortex (BAs 7/40). Simple effects testing indicated a consistent pattern in which patients with schizophrenia exhibited increased activation within both of these regions as a function of stimulus frequency (both Ps<0.05), whereas healthy controls' levels remained at the same level of activation regardless of stimulation frequency (both Ps>0.10).
The main effect of frequency and other second-order interactions (attend-visual and attend-auditory conditions) are not central to the current paper and are presented in the online supplementary Results.
Attend-auditory fMRI results
Similar to the attend-visual results, neither the group×condition nor the group×condition×frequency interaction was significant for attend-auditory trials. There were two different networks that exhibited either increased activation during incongruent trials (CCN) or increased activation during congruent trials (sensory cortices) for attend-auditory trials (see online Fig. DS6 for effects collapsed across group and online Fig. DS7 for individual group effects). Increased activation for incongruent trials was observed in the bilateral anterior insula extending into the ventrolateral prefrontal cortex (BAs 13/45/47), bilateral dorsal medial prefrontal cortex (BAs 24/32) and the left dorsolateral prefrontal cortex/precentral gyrus (BAs 4/6/9). Increased activation for incongruent trials was also observed in the posterior aspects of the left middle and posterior superior temporal gyrus/sulcus (BAs 21/22/39/40), bilateral basal ganglia, midbrain nuclei and thalamus. In contrast, regions of increased activation during congruent trials included both the bilateral ‘what’ (fusiform, parahippocampal gyri and lingual gyri; BAs 18/19/36/37) and ‘where’ (middle occipital gyri, precuneus and cuneus; BAs 7/18/19/31) visual streams, as well as bilateral secondary auditory cortex extending into the precentral gyrus (BAs 13/43/4/6) and left putamen.
For the main effect of group (Fig. 3), patients exhibited hyperactivation within right secondary auditory cortex (BAs 13/43) and bilateral sensorimotor cortex/posterior parietal cortex (inferior and superior aspects; left BAs 2/5/7/40 and right BAs 1/2/3/4/5/6/7/40) during attend-auditory trials. In contrast, in healthy controls, hyperactivation was observed in the left cerebellum. Results remained unchanged when participants with greater than 0.50 mean frame-wise displacement were excluded from analyses. Similar to the attend-visual condition, additional clusters of patient hyperactivation (left auditory cortex) and healthy control deactivation (paracentral lobule and cingulate gyrus) were observed when frame-wise displacement was eliminated from the model. In addition, there were no differences between groups in the left cerebellum when the covariate was eliminated (online Fig. DS8). Examination of the entire HRF (online Fig. DS9) indicated a similar pattern of abnormalities as in the attend-visual condition (increased response amplitude/duration and no post-undershoot for patients with schizophrenia).
Results from two MANCOVAs indicated no significant differences in auditory or visual cortical volume between the two groups (both Ps>0.10).
ARMs analyses (2 (group)×2 (frequency) ANOVAs) indicated trend-level interaction effects within the primary (F 1,64 = 3.88, P = 0.053) and significant interaction effects within the secondary (F 1,64 = 4.05, P<0.05) visual cortex (Fig. 4A and 4B). Simple effects tests indicated a trend for increased ARMs for patients with schizophrenia relative to healthy controls within primary visual cortex (t 64 = −1.73, P = 0.089), with significantly increased ARMs in secondary visual cortex (t 64 = −2.05, P<0.05) during high-frequency trials. There were no significant group differences for low frequency trials (P>0.10). However, one-sample t-tests indicated that robust ARMs were not present in primary or secondary visual cortex for either group (P>0.10).
As predicted, the group×frequency interaction was statistically significant for primary auditory cortex (F 1,64 = 4.09, P<0.05), whereas effects were not significant for secondary auditory cortex (Fig. 4C and 4D). Follow-up simple effects testing indicated no significant (P>0.10) group differences in ARMs for low frequency trials (0.33 Hz). In contrast, patients with schizophrenia exhibited significantly decreased ARMs (t 64 = 2.09, P<0.05) for auditory trials within primary auditory cortex relative to healthy controls during high-frequency trials. One-sample t-tests confirmed that positive modulation (i.e. PSC>0) occurred for healthy controls within primary auditory cortex (t 32 = 3.15, P<0.05) but was absent for patients with schizophrenia (P>0.10) during high-frequency trials. Qualitative examination of secondary auditory cortex (Fig. 4D) also suggested differences in high-frequency trials for patients with schizophrenia relative to healthy controls. One-sample t-tests confirmed the presence of ARMs within secondary auditory cortex for healthy controls (t 32 = 3.05, P<0.05) which were absent for patients with schizophrenia (P>0.10). Collectively, these findings indicate that patients with schizophrenia failed to upregulate unimodal cortical areas at increasing cognitive loads.
Network, behavioural and clinical interactions
Our next series of analyses investigated whether differences in auditory, sensorimotor and posterior parietal cortex were associated with behavioural or clinical findings. Behavioural and functional results indicated a main effect of group, such that data were first averaged across all trials (reaction time and functional activity) and then across voxels (functional data) separately for attend-auditory and attend-visual conditions. Our first set of analyses indicated a positive relationship between reaction time and auditory/parietal activation for both conditions (attend-visual: r = 0.29, P = 0.02; attend-auditory: r = 0.32, P = 0.008) when all participants were included in analyses. These relationships were not significant when only patients with schizophrenia were examined (P>0.10).
Two linear regressions for each condition (attend-auditory and attend-visual) evaluated the relationship between the degree of hyperactivation in these regions for patients only with (a) clinical and neuropsychological measures and with (b) measures of motor pathology. The seven independent variables in the first series of analyses included (a) MATRICS Overall Composite score, (b) UPSA total score, (c) PANSS Conceptual Disorganisation score, (d) PANSS Negative symptoms score, (e) PANSS Positive symptoms score, (f) olanzapine equivalence score and (g) FTND scores. In the second series of analyses, the three independent variables corresponded to potential motor symptoms secondary to medications (AIMS, BAS, SAS). However, the overall model was not significant in any of the four regressions (all Ps>0.10).
The current study investigated whether unisensory cortex, CCN or ARMs would be associated with functional abnormalities during multisensory cognitive control in patients with schizophrenia. Patients had a lower educational attainment and estimate of intelligence, confirming how the typical disease course affects normal activities (e.g. school) and decreases overall cognitive functions. Reference Miller and Chapman26 Current behavioural and functional results indicated successful parametric variation of cognitive load, with high-frequency trials resulting in the expected pattern of increased activation within bilateral unisensory (auditory, visual and sensorimotor) cortex Reference Mayer, Wilcox, Teshiba, Ling and Yang24 and heteromodal cortex (lateral prefrontal and parietal areas), as well as increased posterior default mode network deactivation during both attend-visual and attend-auditory trials. These findings are consistent with previous results Reference Mayer, Franco, Canive and Harrington1,Reference McKiernan, Kaufman, Kucera-Thompson and Binder28 and suggest that the higher frequency trials were more attentionally demanding.
Reaction times were also faster for congruent relative to incongruent trials, and incongruent trials resulted in increased activation within the CCN. Reference Ridderinkhof, van den Wildenberg, Segalowitz and Carter9 Activated nodes from the CCN included the dorsal medial prefrontal cortex, lateral prefrontal cortex, anterior insula, striatum, thalamus and posterior parietal cortex. In addition, the posterior superior temporal sulcus, which plays a critical role in audio-visual sensory integration, Reference Beauchamp, Argall, Bodurka, Duyn and Martin29 also showed evidence of increased activation during incongruent trials. However, the magnitude and volume of differential activation (incongruent>congruent trials) appeared greater for attend-visual relative to attend-auditory condition, suggesting that ignoring auditory distracters may require increased neuronal resources. Activation was also greater for congruent relative to incongruent trials in secondary auditory cortex and primary visual cortex during attend-auditory trials, suggesting that ignoring incongruent visual stimuli did not place additional loads on sensory cortex.
The most pronounced behavioural result was an overall slowing for patients with schizophrenia relative to healthy controls during both attend-visual and attend-auditory trials, which has been previously observed for patients with schizophrenia during auditory Reference Tregellas, Smucny, Eichman and Rojas4,Reference Smucny, Olincy, Eichman, Lyons and Tregellas30 and visual Reference Smucny, Rojas, Eichman and Tregellas6 attentional tasks while attempting to ignore auditory distracters. Specific behavioural deficits in cognitive control in patients with schizophrenia were present during both the attend-auditory (i.e. increased error rate for high-frequency incongruent trials) and attend-visual trials at a trend level (i.e. increased difference in reaction time between incongruent and congruent trials). In contrast, there were no differences in functional activation within the prefrontal nodes of the CCN or thalamus. Importantly, our a priori prediction of cognitive control deficits was tested through an interaction (group×condition), which requires additional statistical power relative to a main effect. Additional analyses indicated small effect sizes between patients with schizophrenia and healthy controls for all major nodes of the CCN, suggesting clinically unmeaningful effects rather than an under-powered sample.
There are several factors which may explain these results. First, recent studies suggest reactive cognitive control tasks such as the Stroop may not be sensitive for revealing deficits in patients with schizophrenia, Reference Lesh, Westphal, Niendam, Yoon, Minzenberg and Ragland2,Reference Edwards, Barch and Braver14 and that deficits are more likely to emerge during proactive cognitive control tasks (e.g. AX continuous performance task). Similar behavioural (overall slowing with no group×condition interaction) and functional (similar levels of activity within the CCN) results were also recently reported in a large cohort of patients with first-episode schizophrenia. Reference Lesh, Westphal, Niendam, Yoon, Minzenberg and Ragland2 However, others have reported deficits during reactive cognitive control tasks, Reference Weiss, Siedentopf, Golaszewski, Mottaghy, Hofer and Kremser7,Reference Ungar, Nestor, Niznikiewicz, Wible and Kubicki11,Reference Weiss, Golaszewski, Mottaghy, Hofer, Hausmann and Kemmler13 suggesting that future studies should include both reactive and proactive cognitive control tasks to further probe this controversy. Second, the nature (multisensory v. unisensory) or difficulty level of the current task may have placed differential demands on cognitive resources relative to previous studies, Reference Minzenberg, Laird, Thelen, Carter and Glahn10 potentially maximising activation within the CCN.
Consistent with a priori predictions and previous results, Reference Smucny, Olincy, Eichman, Lyons and Tregellas30 patients with schizophrenia exhibited hyperactivation in auditory, sensorimotor and posterior parietal cortex during both attend-visual and attend-auditory trials that were associated with the overall pattern of response slowing across both groups. Similar to previous results, Reference Mayer, Ruhl, Merideth, Ling, Hanlon and Bustillo19 qualitative examination of the HRF indicated both an increased amplitude and duration of response, with little evidence of a post-undershoot for patients with schizophrenia (online Figs. DS4 and DS9). Thus, current results indicate a larger role for dysfunction in unisensory and parietal cortex relative to the prefrontal CCN during multisensory reactive cognitive control. Previous findings on the direction of unisensory cortex abnormalities in patients with schizophrenia have been mixed. Several studies have reported patient hyperactivation in response to a number of different experimental conditions. Reference Mayer, Ruhl, Merideth, Ling, Hanlon and Bustillo19,Reference Tregellas, Ellis, Shatti, Du and Rojas31,Reference Arce, Leland, Miller, Simmons, Winternheimer and Paulus32 Hyperactivation of the auditory cortex may be related to either sensory gating or habituation deficits, Reference Patterson, Hetrick, Boutros, Jin, Sandman and Stern18,Reference Ludewig, Geyer and Vollenweider33 and hyperactivation for external stimuli has also been associated with a propensity for auditory hallucinations in healthy controls. Reference Lewis-Hanna, Hunter, Farrow, Wilkinson and Woodruff34 Others report auditory cortex hypoactivation for external stimuli as a rationale for hallucinations, as part of the paradoxical enhancement effect. Reference Kompus, Falkenberg, Bless, Johnsen, Kroken and Krakvik35 Hypoactivation within the lateral prefrontal cortex, fusiform gyrus, temporal-parietal juncture and hippocampus has also been reported during multisensory cognitive control. Reference Smucny, Rojas, Eichman and Tregellas6 These contrasting findings may be secondary to the type of multisensory task and the distracters employed, as distracters in the current study were more directly relevant to the task (i.e. members of the target set).
There were no differential effects of increasing stimulus frequency within auditory or visual unisensory cortex between patients with schizophrenia and healthy controls, suggesting that basic neurovascular coupling in response to increasing sensory demands was similar across both groups. Similarly, there were no differences in primary or secondary unisensory cortical volumes between the two groups. In contrast, similar to previous studies in patients and healthy controls, Reference Mayer, Franco, Canive and Harrington1,Reference Kompus, Falkenberg, Bless, Johnsen, Kroken and Krakvik35 current results indicated that patients with schizophrenia failed to differentially upregulate auditory cortex (ARMs analyses) under higher cognitive loads. The upregulation of unisensory cortex during multisensory tasks may facilitate the suppression of cross-modal distracters Reference Baier, Kleinschmidt and Muller21,Reference Weissman, Warner and Woldorff22 or represent a cross-modal spread of alertness. Reference Regenbogen, De, Debener, Turetsky, Mossnang and Finkelmeyer36 Failure to ‘tune’ auditory cortex under different attentional demands may contribute to impaired performance in patients with schizophrenia across multiple cognitive domains Reference Smucny, Rojas, Eichman and Tregellas6 as well as hallucinations. Reference Kompus, Falkenberg, Bless, Johnsen, Kroken and Krakvik35 There was minimal evidence of ARMs within primary visual cortex for either healthy controls or patients with schizophrenia, although responses were increased for patients. This may be secondary to the relative lack of difficulty for ignoring visual distracters, or result from involvement of other visual pathways (outside of V1 and V2) during attentional allocation.
There are several limitations to the current study. First, patients exhibited increased head motion relative to healthy controls, and motion parameters were not used as nuisance regressors in level-one analyses per convention in mixed designs. We conservatively focused our discussions on findings that survived analyses with frame-wise displacement as a covariate, although several supplemental analyses indicated that differences in head motion did not likely affect results. Second, previous results have indicated reduced volume in unisensory cortex in patients with schizophrenia, Reference Vita, De, Deste and Sacchetti37 and the influence of volume loss on brain activations was not examined in the current study. Third, our ability to detect relationships with clinical variables may have been restricted by the stability (low-level symptomatology) of patients and/or the chronic nature of psychosis in the current sample. Thus, current results may not generalise to other patient samples (e.g. acutely psychotic).
Fourth, healthy controls were excluded for recent depressive episodes rather than a lifetime history, and depression has been shown to affect activation within the CCN. Reference Clasen, Beevers, Mumford and Schnyer38 Fifth, EPI produces auditory background noise secondary to gradient switching that may have differentially affected auditory cortical activity across the two groups. Finally, the full clinical and cognitive battery was not collected on healthy controls due to well-known differences between patients and controls in cognition, smoking and functional outcomes. However, none of these variables were associated with the magnitude of functional activation in the patient cohort. Controls also differed from patients in terms of educational attainment, which is typical for the disease course but may have also contributed to current results.
In summary, current results indicated overall behavioural slowing and functional abnormalities within auditory, sensorimotor/parietal areas during multisensory cognitive control. These behavioural and functional abnormalities were more pronounced while attempting to ignore auditory distracters, with patients also failing to modulate auditory cortex under different attentional demands. Thus, current results suggest that auditory dysfunction may be important for understanding multisensory cognitive control deficits in patients with schizophrenia. Future studies are needed to elucidate whether this issue extends beyond verbal stimuli and whether it can be replicated in unmedicated patients earlier in the disease course.
This work was supported by the National Institutes of Health (grant numbers NIGMS P20GM103472(COBRE), 1R01MH101512-01A1 (R01) to A.R.M.). The funding agencies had no involvement in the study design, data collection, analyses, writing of the manuscript or decisions related to submission for publication.